Kang · Advances in experimental medicine and biology 2026 · narrative review · n=?

Chronotherapy in the Treatment of Major Depression.

Cited 0 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review without systematic search methodology or original data

PubMed 42036581 · doi:10.1007/978-981-95-6872-7_24 · record verified 2026-08-26

What was done

This review examined circadian-targeted interventions for major depressive disorder. It evaluated modalities aimed at resynchronizing circadian rhythms, specifically light therapy, sleep deprivation therapy, sleep phase advance therapy, triple chronotherapy (combining all three approaches), and digital information and communication technology (ICT) delivery tools.

What was found

The abstract reports no quantitative data, effect sizes, sample sizes, or numerical outcomes. It qualitatively notes that chronotherapeutic interventions demonstrate potential for rapid mood improvement and varying degrees of effectiveness, but emphasizes that the evidence base remains constrained by a shortage of systematic and large-scale trials.

Why it matters

Chronotherapy provides a potential non-pharmacological option for rapid symptom relief in major depression, which could be particularly valuable given the multi-week delay of conventional antidepressants and contraindications in specific groups like pregnant patients.

Limits

This is a narrative review that reports no primary empirical data or meta-analytic pooling. The abstract does not specify literature search methods, study inclusion criteria, or total patient numbers reviewed. The underlying literature is constrained by an absence of large-scale, rigorously controlled clinical trials.

Cited by